MX2018012056A - Composiciones farmaceuticas y alimenticias basadas en hafnia alvei para inducir la saciedad y prolongar la saciedad. - Google Patents

Composiciones farmaceuticas y alimenticias basadas en hafnia alvei para inducir la saciedad y prolongar la saciedad.

Info

Publication number
MX2018012056A
MX2018012056A MX2018012056A MX2018012056A MX2018012056A MX 2018012056 A MX2018012056 A MX 2018012056A MX 2018012056 A MX2018012056 A MX 2018012056A MX 2018012056 A MX2018012056 A MX 2018012056A MX 2018012056 A MX2018012056 A MX 2018012056A
Authority
MX
Mexico
Prior art keywords
food compositions
hafnia alvei
inducing satiation
based pharmaceutical
prolonging satiety
Prior art date
Application number
MX2018012056A
Other languages
English (en)
Inventor
BRETON Jonathan
FETISSOV Serguei
Dechelotte Pierre
Lambert Grégory
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2016/051923 external-priority patent/WO2016193829A1/en
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Publication of MX2018012056A publication Critical patent/MX2018012056A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a composiciones farmacéuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesitan. En particular, la presente invención se refiere a un método para inducir la saciedad en un sujeto que lo necesita que comprende administrar al sujeto una cantidad efectiva de Hafnia alvei.
MX2018012056A 2014-10-02 2017-04-05 Composiciones farmaceuticas y alimenticias basadas en hafnia alvei para inducir la saciedad y prolongar la saciedad. MX2018012056A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14306552 2014-10-02
PCT/IB2016/051923 WO2016193829A1 (en) 2015-06-05 2016-04-05 Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof.
PCT/EP2017/058116 WO2017174658A1 (en) 2014-10-02 2017-04-05 Hafnia alvei based pharmaceutical and food compositions for inducing satiation and prolonging satiety

Publications (1)

Publication Number Publication Date
MX2018012056A true MX2018012056A (es) 2019-03-28

Family

ID=51799054

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2017004317A MX2017004317A (es) 2014-10-02 2015-06-05 Composiciones farmaceuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesiten.
MX2017015702A MX2017015702A (es) 2014-10-02 2016-04-05 Composiciones farmaceuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesitan.
MX2018012056A MX2018012056A (es) 2014-10-02 2017-04-05 Composiciones farmaceuticas y alimenticias basadas en hafnia alvei para inducir la saciedad y prolongar la saciedad.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2017004317A MX2017004317A (es) 2014-10-02 2015-06-05 Composiciones farmaceuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesiten.
MX2017015702A MX2017015702A (es) 2014-10-02 2016-04-05 Composiciones farmaceuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesitan.

Country Status (15)

Country Link
US (3) US20170252399A1 (es)
EP (2) EP3200814B1 (es)
JP (3) JP6855372B2 (es)
KR (3) KR20170066543A (es)
CN (2) CN106999545B (es)
AU (2) AU2015332168B2 (es)
BR (2) BR112017006770A2 (es)
CA (2) CA2962907C (es)
ES (3) ES2928379T3 (es)
HK (1) HK1252744A1 (es)
IL (1) IL256136B (es)
MX (3) MX2017004317A (es)
PT (1) PT3439684T (es)
RU (3) RU2717018C2 (es)
WO (2) WO2016059455A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016193829A1 (en) * 2015-06-05 2016-12-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof.
US10729770B2 (en) 2013-12-05 2020-08-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH
RU2717018C2 (ru) * 2014-10-02 2020-03-17 Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) Фармацевтические и пищевые композиции для индукции насыщения и продления чувства сытости у нуждающихся в этом субъектов
EP3384922A1 (en) 2017-04-03 2018-10-10 Targedys Brassicaceae protein extract and uses thereof
FR3076981B1 (fr) * 2018-01-19 2020-01-31 Zhivko Radev Methode de fabrication de produits alimentaires a base de yaourt
CN108715851B (zh) * 2018-04-28 2023-05-16 中山大学 一种斜带石斑鱼摄食调控相关基因AgRP1及其应用
US20210401020A1 (en) * 2018-11-28 2021-12-30 Targedys Hafnia alvei formulations
ES2935711T3 (es) * 2018-11-28 2023-03-09 Targedys Composiciones de Hafnia Alvei que comprenden elementos minerales
EP3841890A4 (en) * 2019-05-22 2021-12-29 Mizkan Holdings Co., Ltd. Insoluble dietary fiber-containing solid composition and method for manufacturing same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997003359A1 (en) * 1995-07-07 1997-01-30 Oravax, Inc. Helicobacter clpb
DE69941212D1 (de) 1998-03-23 2009-09-17 Gen Mills Inc Verkapselung von komponenten in essbaren produkten
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
PL1981516T3 (pl) * 2006-01-27 2019-03-29 Dupont Nutrition Biosciences Aps Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom
JP2009534034A (ja) * 2006-04-19 2009-09-24 ノヴォ ノルディスク アクティーゼルスカブ 原核微生物におけるｏ−グリコシル化治療用タンパク質の発現
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
EP2053122A1 (en) * 2007-10-23 2009-04-29 Nestec S.A. Stress tolerant bifidobacteria
US9173910B2 (en) * 2012-02-29 2015-11-03 The General Hospital Corporation Compositions of microbiota and methods related thereto
WO2016193829A1 (en) * 2015-06-05 2016-12-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof.
US10729770B2 (en) * 2013-12-05 2020-08-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH
WO2015082655A1 (en) * 2013-12-05 2015-06-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) Bacterial influence of host feeding and emotion via clpb protein mimicry of a-msh
WO2015082633A1 (en) * 2013-12-05 2015-06-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) Bacterial influence on regulation of appetite via clpb protein mimicry of alpha-msh
RU2717018C2 (ru) * 2014-10-02 2020-03-17 Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) Фармацевтические и пищевые композиции для индукции насыщения и продления чувства сытости у нуждающихся в этом субъектов

Also Published As

Publication number Publication date
AU2015332168A1 (en) 2017-04-20
MX2017004317A (es) 2017-10-04
RU2017110516A3 (es) 2018-11-05
RU2766585C2 (ru) 2022-03-15
EP3769777B1 (en) 2022-07-27
US20200297783A1 (en) 2020-09-24
EP3200814B1 (en) 2020-09-23
BR112017006770A2 (pt) 2018-11-06
MX2017015702A (es) 2018-12-11
AU2016272850A1 (en) 2017-12-21
KR102472169B1 (ko) 2022-11-29
EP3200814A1 (en) 2017-08-09
CA2962907C (en) 2022-06-07
ES2928379T3 (es) 2022-11-17
ES2808939T3 (es) 2021-03-02
US10888592B2 (en) 2021-01-12
PT3439684T (pt) 2020-07-31
WO2017174658A1 (en) 2017-10-12
KR20170066543A (ko) 2017-06-14
CN106999545A (zh) 2017-08-01
JP2018521982A (ja) 2018-08-09
JP2018503597A (ja) 2018-02-08
IL256136B (en) 2021-02-28
KR20180011841A (ko) 2018-02-02
CN109310736A (zh) 2019-02-05
ES2828952T3 (es) 2021-05-28
AU2015332168B2 (en) 2021-02-25
CN106999545B (zh) 2021-09-21
HK1252744A1 (zh) 2019-05-31
BR112017026241A2 (pt) 2018-09-11
EP3769777B9 (en) 2022-10-26
CA3020050A1 (en) 2017-10-12
RU2018138995A (ru) 2020-05-12
WO2016059455A1 (en) 2016-04-21
RU2717018C2 (ru) 2020-03-17
JP6855372B2 (ja) 2021-04-07
RU2017142932A3 (es) 2019-07-17
US20170252399A1 (en) 2017-09-07
EP3769777A1 (en) 2021-01-27
RU2017110516A (ru) 2018-11-05
JP6987122B2 (ja) 2022-01-05
KR20190010543A (ko) 2019-01-30
US20190142876A1 (en) 2019-05-16
RU2017142932A (ru) 2019-07-11
JP2019513832A (ja) 2019-05-30
US11389489B2 (en) 2022-07-19
CN109310736B (zh) 2022-09-13
CA2962907A1 (en) 2016-04-21
IL256136A (en) 2018-02-28
JP6876627B2 (ja) 2021-06-02
RU2018138995A3 (es) 2020-11-09

Similar Documents

Publication Publication Date Title
MX2018012056A (es) Composiciones farmaceuticas y alimenticias basadas en hafnia alvei para inducir la saciedad y prolongar la saciedad.
IL259092B (en) Pharmaceutical compounds and methods and labeling for indoleamine 2,3-dioxygenase inhibitor
HK1232141A1 (zh) 用於治療亨廷頓病的方法和組合物
MY182667A (en) Food compositions comprising one or both of recombinant beta-lactoglobulin protein and recombinant alphalactalbumin protein
GB2541571A (en) Pharmaceutical compositions
GEP20207075B (en) New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them
PT3782617T (pt) Composições farmacêuticas de gel compreendendo levodopa, carbidopa e entacapona
MX2017004808A (es) Combinaciones que comprenden siponimod y laquinimod para el tratamiento de la esclerosis multiple.
IL304535A (en) connector and sheath for end-to-side nerve connection (es)
IL248785B (en) Antecedents of ]-n5,1-dimethyl3--oxo-(3,2-dihydro-h1-pyrazol-4-yl)]-methyl-isoxazole-3-carboxamide and pharmaceutical preparations including these antecedents
MX2020009444A (es) Composicion farmaceutica oral de isotretinoina con dosis baja y su proceso de preparacion.
PH12017502028A1 (en) Vortioxetine pyroglutamate
IL258507A (en) Methods and compositions for unwanted or abnormal muscle contractions
IL247099A0 (en) Beta-converted amino acids and their analogs, preparations containing them and their uses
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
IL265831A (en) Preparations and methods for protein expression and administration
EP3189849A4 (en) Novel peptide for inhibiting fat accumulation, and pharmaceutical composition for preventing or treating obesity, comprising same
PH12017500602A1 (en) Methods for treating ocular conditions
IN2014CH00840A (es)
TR201908639T4 (tr) Dejeneratif göz bozukluklarının önlenmesi ve veya tedavisine yönelik safran bazlı bileşimler.
GR2003061Y (el) Συσκευασια για θερμικως επεξεργασμενο κρεατοσκευασμα, με δυνατοτητα ευκολου ανοιγματος
MX2016009056A (es) Composiciones y metodos para tratamiento de crecimiento celular anormal.
AU2017247612A9 (en) Hafnia alvei based pharmaceutical and food compositions for inducing satiation and prolonging satiety
EP3216456A4 (en) Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency
EP3097918A4 (en) Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency